Results 281 to 290 of about 125,004 (342)

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Impact of sequential administration of detomidine, butorphanol, and midazolam on sedation, ataxia, stimulus response, and bispectral index in horses. [PDF]

Front Vet Sci
Thorn CA, Wilson DV, Wang S, Horne WA.
europepmc   +1 more source

Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review

Addiction, EarlyView.
Abstract Background and aims There has been limited evidence synthesis examining the treatment of buprenorphine precipitated opioid withdrawal (BPOW). We aimed to conduct the first systematic review to assess the clinical utility of any pharmacological intervention in the management of BPOW.
Emmert Roberts, Nicola Kalk, John Strang
wiley   +1 more source

Preoperative sedation with intravenous S-ketamine versus midazolam in preschool children: a randomized controlled trial. [PDF]

BMC Anesthesiol
Liao YQ, Ma J, He Y, Su YW, Xu MZ, Zhang MQ.   +5 more
europepmc   +1 more source

Economic evidence for licensed ready‐to‐administer intravenous products compared with standard vials and ampoules: a systematic review

Anaesthesia, EarlyView.
Summary Introduction Injectable medicines represent a significant proportion of the annual medicines expenditure of the NHS in England, totalling £7 billion ($9.4 billion, €8.0 billion) in 2023. This represents approximately 70% of hospital medicines spending and includes essential treatments delivered at the point of care, such as chemotherapy ...
Suzanne Al‐Rawi, Matthew Greening, Sue Ladds   +2 more
wiley   +1 more source

Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin. [PDF]

Hum Psychopharmacol
Freitas da Costa B, Hartmann P, Pagnin D.   +2 more
europepmc   +1 more source

An Archaeometallurgical Investigation on Some Archaeological Metal Finds From the Sasanian Site of Jahāngir, Western Iran

Archaeometry, EarlyView.
ABSTRACT Twelve metal artifacts from recent excavations at the Sasanian archaeological site of Jahāngir in western Iran have been analyzed. These items include both decorative and utilitarian artifacts. The samples were examined using micro‐X‐ray fluorescence (μ‐XRF), scanning electron microscopy with energy‐dispersive X‐ray spectroscopy (SEM‐EDS), and
Omid Oudbashi, Leila Khosravi, Morteza Habibzadeh   +2 more
wiley   +1 more source

A Population Pharmacokinetic Approach to Understand the Effect of Efavirenz on CYP3A Activity in Healthy Volunteers Using Midazolam as a Probe. [PDF]

CPT Pharmacometrics Syst Pharmacol
Collins KS, Aruldhas BW, Metzger IF, Lu JBL, Heathman MA, Quinney SK, Desta Z.   +6 more
europepmc   +1 more source

Remimazolam used for sedation during spinal anesthesia puncture provides faster sedation effect and increase recovery rate compared to midazolam: a randomized controlled trial. [PDF]

Front Pharmacol
Sun P, Tan Z, Liang L, Zhang J, Li X.
europepmc   +1 more source